Production (Stage)
Dr. Reddy's Laboratories Limited
RDY
$15.80
-$0.37-2.29%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.21% | 14.17% | 15.00% | 12.14% | 11.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.21% | 14.17% | 15.00% | 12.14% | 11.34% |
| Cost of Revenue | 23.56% | 13.65% | 12.45% | 7.52% | 7.70% |
| Gross Profit | 9.30% | 14.54% | 16.80% | 15.39% | 14.07% |
| SG&A Expenses | 14.27% | 17.49% | 20.83% | 26.24% | 11.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -99.58% | 14.37% | -45.82% | 42.21% | -58.37% |
| Total Operating Expenses | 16.52% | 15.74% | 17.23% | 16.44% | 10.56% |
| Operating Income | 10.35% | 9.05% | 7.94% | 0.02% | 14.32% |
| Income Before Tax | 20.12% | 1.16% | -1.12% | 0.40% | 19.60% |
| Income Tax Expenses | 36.19% | 3.75% | 31.00% | 8.76% | -20.39% |
| Earnings from Continuing Operations | 16.50% | 0.33% | -10.53% | -2.25% | 34.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.99% | 1.01% | -16.28% | -2.25% | 34.87% |
| EBIT | 10.35% | 9.05% | 7.94% | 0.02% | 14.32% |
| EBITDA | 12.25% | 11.66% | 7.12% | 0.88% | 13.69% |
| EPS Basic | 16.93% | 0.96% | -16.40% | -2.48% | 34.52% |
| Normalized Basic EPS | 17.96% | 3.90% | 1.42% | -0.74% | 20.48% |
| EPS Diluted | 16.96% | 0.91% | -16.34% | -2.39% | 34.59% |
| Normalized Diluted EPS | 18.06% | 3.91% | 1.43% | -0.68% | 20.43% |
| Average Basic Shares Outstanding | 0.07% | 0.08% | 0.13% | 0.21% | 0.24% |
| Average Diluted Shares Outstanding | 0.00% | 0.07% | 0.09% | 0.16% | 0.21% |
| Dividend Per Share | -4.05% | -- | -- | -- | -1.03% |
| Payout Ratio | -- | -- | 0.18% | -- | -- |